|
Market Cap (24-Jun) $24,941,990 (1,259th) |
Close (30-Jun) $0.080 |
Volume (30-Jun) 244,049 |
Shortsold (15-Jan) 38,875 (0.01%) (540th) |
|
52w High $0.260 |
52w Low $0.059 |
P/E - |
EPS -0.02 |
NSB released this announcement to the ASX on 15 November 2022, 16:27. The announcement is not marked as price sensitive, and is 2 page(s) in length and 142.13kb in size.
You can view all announcements from NSB and see how they appear on a price chart on the announcements page.
At the date of this announcement, NSB was 0.012% short sold according to ASIC data. It was ranked the 617th most shorted stock on the ASX. It is now ranked as the 540th most shorted stock on the ASX with 0.012% of total shares short sold as of the latest reported data (15 January 2026).
| Other Recent Announcements from NSB | |
|---|---|
| Change of Director's Interest Notice - Rennie | 7 June 2023, 8:22 |
| Change of Director's Interest Notice - Uvarov | 25 May 2023, 15:30 |
| Change of Director's Interest Notice - Rennie | 25 May 2023, 15:07 |
| Executive Management Changes | 15 November 2022, 16:27 |
| NSB receives R&D Advance & Overseas Finding | 14 November 2022, 17:23 |
| Quarterly Activities/Appendix 4C Cash Flow Report | 31 October 2022, 7:56 |
| Notice of Annual General Meeting | 21 October 2022, 8:18 |
You must be logged in to post a reply.
NeuroScientific Biopharmaceuticals 